Work

Correction: Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States

Year: 2025

Type: erratum

Source: Infectious Diseases and Therapy

DOI: 10.1007/s40121-025-01266-4

Authors: Michele Wilson, Yoav Golan, Dianne Nguyen, Morteza Yazdani, Alpesh N. Amin

Institutions: RTI Health Solutions, Tufts Medical Center, Nestlé Health Science (United States), Nestlé (Switzerland), University of California, Irvine

Language: English

Topic: Clostridium difficile and Clostridium perfringens research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $7,400

OpenAlex ID: W4416399656

Cites:

Cited by:

Related to: